FDA Commissioner Says He Will Study Abortion Pill after Study Links It to Severe Injuries

Robert Jones : Jun 6, 2025
LifeSiteNews.com

If you've taken mifepristone, it may not be too late. Abortion Pill Reversal reports that over 6,000 lives have been saved using a progesterone protocol. More information is available here.

(Washington, DC) — [LifeSiteNews.com] FDA Commissioner Marty Makary says the agency will review the abortion drug mifepristone following a study that links it to serious medical complications in thousands of women. (Image credit: Robin Marty-Flickr /CC-BY-2.0)

In a letter to Sen. Josh Hawley (R-MO) this week, Makary acknowledged a peer-reviewed study showing that one in nine women experienced sepsis, infection, or hemorrhage within six weeks of taking the drug—rates Hawley said are 22 times higher than what the label currently indicates.

The study, from the Ethics and Public Policy Center, analyzed over 860,000 abortion-related insurance claims between 2017 and 2023.

Makary said the FDA would assess the data, adding that the agency "continues to closely monitor" safety outcomes.

As recently as April 2025, Makary had stated he had "no plans to take action" on mifepristone, even after raising concerns during his confirmation. The review was initiated only after Hawley's intervention.

Chemical abortion now accounts for over half of all US abortions— 63 percent in 2023, according to the pro-abortion Guttmacher Institute. It has been defended by politicians across the world, including the Trump DOJ and US Vice President JD Vance.

The Supreme Court dismissed a challenge to the FDA's policy last year on procedural grounds, without addressing the underlying safety questions... Subscribe for free to Breaking Christian News here

Continue reading Here.